This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Algeta To Host Capital Markets Days

OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) --

Intended for US media only

Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will host Capital Markets
Days this week in Oslo, London and New York.

Event summaries and guest speaker details are provided below.

Oslo, 18 November 10:00am-2:00pm (CET)
KS-Agenda Møtesenter, Haakon VII's gate 9

  * Dr Dag Clement Johannessen, Consultant Oncologist, Department of Oncology,
    University Hospital of Oslo, Norway
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

London, 19 November 10:00am-2:00pm (GMT)
Holborn Bars 2(nd) Floor, 138-142 Holborn

  * Dr E. David Crawford, Professor of Surgery (Urology) & Radiation Oncology,
    Head Urologic Oncology, University of Colorado, Denver, USA
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

New York, 21 November 12.30pm-4:30pm (EDT)
Parker Meridien, 118 West 57(th) Street

  * Dr Dan George, Director, GU Oncology, Duke Cancer Institute, Duke University
    Medical Center, Durham, North Carolina, USA
  * Dr Neal D. Shore, Director, CPI, Carolina Urologic Research Center, Atlantic
    Urology Clinics, Myrtle Beach, South Carolina, USA

The  event in New  York will be  webcast via www.algeta.com, where presentations
will also be made available.


                                      ###

For further information, please contact:

 Mike Booth                             +1 646 410 1884

 Communications & Corporate Affairs     ir@algeta.com



 Media enquiries:

 Mark Swallow                           +44 207 638 9571

 Citigate Dewe Rogerson                 mark.swallow@citigatedr.co.uk



 Kari Watson                            +1 781 235 3060

 MacDougall Biomedical Communications   kwatson@macbiocom.com



 Investor enquiries:

 Tricia Truehart                        +1 646 378 2953

 The Trout Group                        ttruehart@troutgroup.com


About Algeta

Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit
www.algeta.com.




Press release: http://hugin.info/134655/R/1743766/586643.pdf

[HUG#1743766]

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs